Clinical outcomes of COVID-19 in patients with sickle cell disease and sickle cell trait: A critical appraisal of the literature
WS Hoogenboom, TT Alamuri, DM McMahon… - Blood reviews, 2022 - Elsevier
Individuals with sickle cell disease (SCD) and sickle cell trait (SCT) have many risk factors
that could make them more susceptible to COVID-19 critical illness and death compared to …
that could make them more susceptible to COVID-19 critical illness and death compared to …
COVID-19 and hemoglobinopathies: a systematic review of clinical presentations, investigations, and outcomes
This systematic review aimed to provide an overview of the clinical profile and outcome of
COVID-19 infection in patients with hemoglobinopathy. The rate of COVID-19 mortality and …
COVID-19 infection in patients with hemoglobinopathy. The rate of COVID-19 mortality and …
Comorbidities are risk factors for hospitalization and serious COVID-19 illness in children and adults with sickle cell disease
L Mucalo, AM Brandow, M Dasgupta… - Blood …, 2021 - ashpublications.org
Patients with sickle cell disease (SCD) are at high risk of developing serious infections,
therefore, understanding the impact that severe acute respiratory syndrome coronavirus 2 …
therefore, understanding the impact that severe acute respiratory syndrome coronavirus 2 …
Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection
We aimed to identify predictors of outcomes and survival in patients living in 4 major
metropolitan areas who had sickle cell disease (SCD) and COVID-19 to inform best …
metropolitan areas who had sickle cell disease (SCD) and COVID-19 to inform best …
COVID-19 in individuals with sickle cell disease/trait compared with other Black individuals
A Singh, AM Brandow, JA Panepinto - Blood advances, 2021 - ashpublications.org
Abstract In the United States, COVID-19 has disproportionately affected Black persons.
Sickle cell disease (SCD) and sickle cell trait (SCT) are genetic conditions that occur …
Sickle cell disease (SCD) and sickle cell trait (SCT) are genetic conditions that occur …
Initial guidance on use of monoclonal antibody therapy for treatment of coronavirus disease 2019 in children and adolescents
J Wolf, MJ Abzug, RL Wattier, PK Sue… - Journal of the …, 2021 - academic.oup.com
Abstract Background In November 2020, the US Food and Drug Administration (FDA)
provided Emergency Use Authorizations (EUA) for 2 novel virus-neutralizing monoclonal …
provided Emergency Use Authorizations (EUA) for 2 novel virus-neutralizing monoclonal …
[HTML][HTML] COVID-19 and sickle cell disease
LA Menapace, SL Thein - Haematologica, 2020 - ncbi.nlm.nih.gov
The spread of the novel SARS-CoV-2 coronavirus (COVID-19) has resulted in widespread
lockdowns and an unprecedented number of deaths globally. 1, 2 The pandemic has posed …
lockdowns and an unprecedented number of deaths globally. 1, 2 The pandemic has posed …
Sickle cell disease and COVID‐19: Susceptibility and severity
We surveyed published papers and an international sickle cell disease (SCD) registry to
detect susceptibility and clinical course of coronavirus disease 2019 (COVID‐19) in SCD …
detect susceptibility and clinical course of coronavirus disease 2019 (COVID‐19) in SCD …
[HTML][HTML] Impact of COVID-19 on vasooclusive crisis in patients with sickle cell anaemia
S Alkindi, RA Elsadek, A Al-Madhani… - International Journal of …, 2021 - Elsevier
Objectives The study aimed to assess COVID-19 impact on the morbidity and mortality of
vasooclusive crisis (VOC) in sickle cell anaemia (SCA) patients. Methods A prospective …
vasooclusive crisis (VOC) in sickle cell anaemia (SCA) patients. Methods A prospective …
Hemoglobinopathy and pediatrics in the time of COVID-19
Introduction: It is important to know if patients with hemoglobinopathy could be more
susceptible to COVID-19. Objective: Analyze SARS-CoV-2 infection in pediatric patients with …
susceptible to COVID-19. Objective: Analyze SARS-CoV-2 infection in pediatric patients with …